Cargando…

Mechanisms of Hearing Loss in Neurofibromatosis Type 2

INTRODUCTION: Patients with neurofibromatosis type 2 (NF2) develop bilateral cochleovestibular schwannomas (CVSs) that cause binaural deafness in most individuals. Hearing loss occurs in an unpredictable manner and the underlying mechanisms are not known. To gain insight into the pathophysiologic ba...

Descripción completa

Detalles Bibliográficos
Autores principales:	Asthagiri, Ashok R., Vasquez, Raul A., Butman, John A., Wu, Tianxia, Morgan, Keaton, Brewer, Carmen C., King, Kelly, Zalewski, Chris, Kim, H. Jeffrey, Lonser, Russell R.
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Public Library of Science 2012
Materias:	Research Article
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3458837/ https://www.ncbi.nlm.nih.gov/pubmed/23049959 http://dx.doi.org/10.1371/journal.pone.0046132

Ejemplares similares

CHD7 variants associated with hearing loss and enlargement of the vestibular aqueduct
por: Roux, Isabelle, et al.
Publicado: (2023)

Hearing Loss and Irritability Reporting Without Vestibular Differences in Explosive Breaching Professionals
por: Modica, Claire M., et al.
Publicado: (2020)

Neurofibromatosis 2: hearing restoration options
por: Monteiro, Tatiana Alves, et al.
Publicado: (2015)

Tumors displaying hybrid schwannoma and neurofibroma features in patients with neurofibromatosis type 2
por: Montgomery, Blake K., et al.
Publicado: (2016)

Genetic Hearing Loss Associated With Autoinflammation
por: Nakanishi, Hiroshi, et al.
Publicado: (2020)

Characterization of hearing-impairment in Generalized Arterial Calcification of Infancy (GACI)
por: Theng, Elizabeth H., et al.
Publicado: (2022)

Hearing Restoration in Neurofibromatosis Type II Patients
por: Lee, Jeon Mi, et al.
Publicado: (2016)

Chemopreventative celecoxib fails to prevent schwannoma formation or sensorineural hearing loss in genetically engineered murine model of neurofibromatosis type 2
por: Wahle, Benjamin M., et al.
Publicado: (2017)

Comparative clinical and genomic analysis of neurofibromatosis type 2-associated cranial and spinal meningiomas
por: Pemov, Alexander, et al.
Publicado: (2020)

Cyclodextrins and Iatrogenic Hearing Loss: New Drugs with Significant Risk
por: Crumling, Mark A., et al.
Publicado: (2017)

Neurofibromatosis : revisión bibliográfica /
por: León Mendoza, Raúl
Publicado: (1987)

Cochlear implant in type 2 neurofibromatosis: an option for better hearing rehabilitation
por: Cruz, Oswaldo Laércio M., et al.
Publicado: (2015)

Effects of Cochlear Implantation on Binaural Hearing in Adults With Unilateral Hearing Loss
por: Buss, Emily, et al.
Publicado: (2018)

A review of the effects of unilateral hearing loss on spatial hearing
por: Kumpik, Daniel P., et al.
Publicado: (2019)

Trajectory of hearing loss in children with unilateral hearing loss
por: Fitzpatrick, Elizabeth M., et al.
Publicado: (2023)

Laboratory methods of assessing hearing loss.
por: Møller, A R
Publicado: (1982)

Pediatric otosyphilis—An unusual cause of conductive hearing loss
por: Arain, Zoya, et al.
Publicado: (2019)

Discrimination Task Reveals Differences in Neural Bases of Tinnitus and Hearing Impairment
por: Husain, Fatima T., et al.
Publicado: (2011)

Autoimmune hearing loss and ulcerative colitis
por: Prescinotto, Renato, et al.
Publicado: (2015)

Plexiform neurofibromatosis
por: Avhad, Ganesh, et al.
Publicado: (2014)

Hearing loss at work? Hearing loss from leisure activities?
Publicado: (2006)

First insight into the somatic mutation burden of neurofibromatosis type 2-associated grade I and grade II meningiomas: a case report comprehensive genomic study of two cranial meningiomas with vastly different clinical presentation
por: Dewan, Ramita, et al.
Publicado: (2017)

Idiopathic sensorineural hearing loss in the only hearing ear
por: Berrettini, S., et al.
Publicado: (2016)

Cochlear Implantation in Patients with Neurofibromatosis Type 2 and Patients with Vestibular Schwannoma in the Only Hearing Ear
por: Celis-Aguilar, Erika, et al.
Publicado: (2012)

Impact of Surgery on Long-Term Results of Hearing in Neurofibromatosis Type-2 Associated Vestibular Schwannomas
por: Gugel, Isabel, et al.
Publicado: (2019)

Cochlear Implantation in Cases of Asymmetric Hearing Loss: Subjective Benefit, Word Recognition, and Spatial Hearing
por: Dillon, Margaret T., et al.
Publicado: (2020)

Personalized Medicine for Nervous System Manifestations of von Hippel–Lindau Disease
por: Schunemann, Victoria, et al.
Publicado: (2016)

Hearing loss in children with Fabry disease
por: Suntjens, E., et al.
Publicado: (2017)

Metaplastic breast cancer in a patient with neurofibromatosis type 1 and somatic loss of heterozygosity
por: Suarez-Kelly, Lorena P., et al.
Publicado: (2018)

Preventing Hearing Loss and Restoring Hearing: A New Outlook
por: Vlajkovic, Srdjan M., et al.
Publicado: (2015)

Neurofibromatosis
por: Gerber, PA, et al.
Publicado: (2009)

Neurofibromatosis
por: Hovinga, Koos E., et al.
Publicado: (2020)

Emerging options in immune‐mediated hearing loss
por: Sakano, Hitomi, et al.
Publicado: (2018)

NIOSH Hearing Loss Prevention Program for Mining
por: Peterson, Jeffrey Shawn, et al.
Publicado: (2023)

COVID-19 in people with neurofibromatosis 1, neurofibromatosis 2, or schwannomatosis
por: Banerjee, Jineta, et al.
Publicado: (2023)

Hearing Loss in Stickler Syndrome: An Update
por: Acke, Frederic R. E., et al.
Publicado: (2022)

Troglitazone Reduces Glyoxalase I Protein Expression in Glioma and Potentiates the Effects of Chemotherapeutic Agents
por: Helgager, Jeffrey, et al.
Publicado: (2010)

Loss of Quiescence in von Hippel-Lindau Hemangioblastomas is Associated with Erythropoietin Signaling
por: Feldman, Michael J., et al.
Publicado: (2016)

Prognostic factors in sudden hearing loss
por: Enache, R, et al.
Publicado: (2008)

The role of hypoxia-associated miRNAs in acquired sensorineural hearing loss
por: Safabakhsh, Sina, et al.
Publicado: (2022)

Cannot write session to /tmp/vufind_sessions/sess_cep011v3hb7adm5bkvom6rq6c9